ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar NicolasDarvas (< 20) Submitted: 1/8/2011 9:23:39 PM : Outperform Start Price: $17.45 VPHM Score: +10.94

stockmillionare.

Featured Broker Partners


Advertisement